Erfan, G. Et Al. 2017. Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors.. Acta dermato-venereologica , vol.97, no.2 , 258-260.

Erfan, G., Puig, S., Carrera, C., Arance, A., Gaba, L., Victoria, I., ... Garcia-Herrera, A.(2017). Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors.. Acta dermato-venereologica , vol.97, no.2, 258-260.

Erfan, GAMZE Et Al. "Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors.," Acta dermato-venereologica , vol.97, no.2, 258-260, 2017

Erfan, GAMZE Et Al. "Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors.." Acta dermato-venereologica , vol.97, no.2, pp.258-260, 2017

Erfan, G. Et Al. (2017) . "Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors.." Acta dermato-venereologica , vol.97, no.2, pp.258-260.

@article{article, author={GAMZE ERFAN Et Al. }, title={Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors.}, journal={Acta dermato-venereologica}, year=2017, pages={258-260} }